期刊文献+

慢性丙型肝炎患者的糖代谢异常及其危险因素 被引量:9

Glycometabolism in Patients with Chronic Hepatitis C and Their Risk Factors
下载PDF
导出
摘要 目的明确慢性丙型肝炎患者糖代谢异常(空腹血糖升高与Ⅱ型糖尿病)的发生率,探讨其临床特征及相关危险因素。方法用荧光定量聚合酶链反应(fluorogenic quantitative polymerase chain reaction,PCR)法对152例慢性丙型肝炎(chronic hepatitis C,CHC)(其中54例合并丙型肝炎性肝硬化)患者与82例慢性乙型肝炎(chronic hepatitis B,CHB)(其中30例合并乙型肝炎性肝硬化)患者进行血清丙型肝炎病毒(hepatitis Cvirus,HCV)RNA和HCV基因型的检测。将肝硬化患者按child-pugh分级标准分为child A、B、C3组。比较CHC与CHB2组患者Ⅱ型糖尿病发病率的差异,探讨HCV感染易发生糖代谢异常的相关危险因素。结果①CHC患者空腹血糖升高的发生率为24.8%,Ⅱ型糖尿病发病率为19.2%,肝硬化患者合并Ⅱ型糖尿病的发病率为25.9%;childpugh A、B、C3型患者分别为17.4%,29.2%和42.9%。②CHB患者的Ⅱ型糖尿病发生率为9.7%,肝硬化患者占6.7%,childpugh A、B、C3型患者分别为0%,0%和6.7%。③CHC患者Ⅱ型糖尿病发生率高于CHB患者,差异有统计学意义(P<0.01)。④多元回归分析表明,基因1b型、年龄、高血压、肝硬化是慢性丙型肝炎患者合并Ⅱ型糖尿病的危险因素(P<0.01)。结论CHC患者易发生糖代谢异常,是否合并Ⅱ型糖尿病与基因1b型、肝硬化、高血压和年龄相关。 Objective To study the prevalence of abnormal glucose metabolism in patients with chronic hepatitis C and their clinical features and risk factors. Methods We retrospectively analyzed 152 patients with chronic hepatitis C(54 with liver cirrhosis) and 82 with chronic hepatitis B(30 with liver cirrhosis ). Results ① The prevalence of impaired fasting glucose and diabetes mellitus in patients with chronic hepatitis C was 24.8% and 19.2%,respectively. The occurrence of diabetes mellitus in patients with liver cirrhosis was 25.9%,and in patients with child-pugh A,B and C the occurrence was 17.4%,29.2%,42.9%,respectively. ② The prevalence of diabetes mellitus in patients with chronic hepatitis B was 9.7 %,and in liver cirrhosis(child-pugh C) was 6.7%. ③ The prevalence of type Ⅱ diabetes in patients with CHC was significantly higher than that in patients with CHB(P〈0.01). ④ By Logistic regression analysis,risk factors associated with T2MD of CHC patients were genotype 1b,age,hypertensive,liver cirrohosis. Conclusion A considerable proportion of patients with CHC had abnormalities in glucose metabolism and type Ⅱ diabetes,and an increased prevalence of type Ⅱ diabetes was found associated with age,hypertension,genotype 1b and liver cirrhosis.
出处 《首都医科大学学报》 CAS 北大核心 2009年第6期791-794,共4页 Journal of Capital Medical University
基金 国家十一五重大专项课题(2008ZX10002-013) 国家自然科学基金(30771906)资助项目~~
  • 相关文献

参考文献9

  • 1Moucari R, Asselah T, Cazals-Hatem D, et al. Insulin Resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis[J]. Gastroenterology, 2008,134:416-423. 被引量:1
  • 2Zein C O, Levy C, Basu A, et al. Chronic hepatitis C and type II diabetes mellitus:a prospective cross-sectional study [ J ]. Am J Gastoenterology, 2005,100:48-55. 被引量:1
  • 3Grimbert S, Valensi P, Levy-Marchal C, et al. High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case control study[ J]. Gastroenterol Clin Biol,1996, 20:544-548. 被引量:1
  • 4Laskus T, Radkowski M, Wang L F, et al. Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunedeficiency syndrome:specific detection of negative-strand viral RNA in tissues [ J ]. Hepatology, 1998,28 : 1398- 1401. 被引量:1
  • 5Hotamisligil G S, Shargill N S, Spiegelman B M, et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance[ J]. Science, 1993, 259:87-91. 被引量:1
  • 6Aguirre V, Werner E D, Giraud J, et al. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action [ J ]. J Biol Chem, 2002, 277:1531-1537. 被引量:1
  • 7Hotamisligil G S, Peraldi P, Budavari A, et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance [J ]. Science, 1996,271:665-668. 被引量:1
  • 8Ueki K, Kondo T, Kahn C R, et al. Suppressor of cytokine signaling 1 ( SOCS-1 ) and SOCS-3 cause insulin resistance through Inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms [ J ]. Mol Cell Biol, 2004,24:5434- 5446. 被引量:1
  • 9Cua I H, Hui J M, Bandara P, et al. Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines [ J ]. Hepatology, 2007,46 : 66-73. 被引量:1

同被引文献66

引证文献9

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部